Randomized double-blind, placebo-controlled clinical trial for Bu-Shen Jiang-Ya Granules in treating patients with essential hypertension of kidney deficiency type

Not Applicable

Recruiting

• Conditions: essential hypertension

• Registration Number: ITMCTR1900002876
• Lead Sponsor: Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Aged 18 to 75 years old;
2. patients diagnosed with mild to moderate essential hypertension diagnosed by western medicine: continuous blood pressure or 3 or more non-same day sitting systolic blood pressures >=140 mmHg and <180 mmHg and / or diastolic blood pressure >=90 mmHg and <110 mmHg;
3. The diagnosis of TCM accorded with kidney deficiency syndrome;
4. the patients signed informed consent.

Exclusion Criteria

1. Secondary hypertension (symptomatic hypertension);
2. severe heart failure;
3. insulin-dependent diabetes mellitus;
4. infectious disease;
5. hyperthyroidism;
6. Patients with primary diseases such as liver, kidney, hematopoietic system, nervous system, and psychiatric diseases, malignant tumors;
7. patients participating in other clinical trials;
8. pregnant or lactating women;
9. recent history of trauma.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
24-hour ambulatory blood pressure;Office blood pressure;

Secondary Outcome Measures

Name	Time	Method
Quality of Life;